CRISPR editing of mtNPM1 inhibits enhancers, mRNA gene-sets, mRNA targets of HOXA9/MEIS1, c-Myc and c-Myb, and core regulatory circuitry (CRC). Here, MYB is linked to colorectal carcinoma.